Nath bio-genes (I) Ltd. has submitted its compliance certificate for the quarter ended 31st March 2026 to both BSE Limited and National Stock Exchange of India Ltd. The submission fulfills the regulatory requirements under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Details

The compliance certificate was received from M/s Bigshare Services Pvt. Ltd., which serves as the Registrar and Share Transfer Agent for the company. The certificate was submitted on 15th April 2026 by Amol Gupta, Chief Financial Officer of Nath Bio-Genes (India) Limited.

Certificate Confirmation

Bigshare Services Pvt. Ltd. confirmed in their certificate dated 06/04/2026 that securities received from depository participants for dematerialization up to 31st March 2026 were properly confirmed to the depositories. The registrar verified that all securities comprised in the certificates have been listed on the stock exchange where the earlier issued securities are listed.

Dematerialization Process Compliance

The certificate confirms that security certificates received for dematerialization have been mutilated and cancelled after due verification by the depository participant. Additionally, the names of the depositories have been substituted in the register of members as registered owners within 15 days of receipt of certificate of securities, ensuring full compliance with regulatory requirements.

Company Information

Nath Bio-Genes (I) Ltd. operates under CIN L01110MH1993PLC072842 and maintains offices in Aurangabad and Mumbai. The company's securities are traded on BSE under code 537291 and on NSE under the symbol NATHBIOGEN.

Tapovan Paper and Board Mills Limited has disclosed the acquisition of 75,645 equity shares in Nath Bio-Genes (India) Limited, representing 0.40% of the target company's total paid-up equity share capital. The acquisition occurred through a scheme of arrangement and amalgamation that was sanctioned by the National Company Law Tribunal (NCLT), Mumbai Bench on November 26, 2025.

Amalgamation Details

The scheme involved the amalgamation of five transferor companies with Tapovan Paper and Board Mills Limited as the transferee company. The transferor companies included Jeevan Farms Private Limited, Nath Securities Limited, Paresh Farms Private Limited, Prabha Farms Private Limited, and Wexford Trading Company Private Limited. All these entities have ceased to exist following the completion of the amalgamation process.

The NCLT order was communicated on December 19, 2025, and the effective date of the share transfer was January 9, 2026, coinciding with the filing of Form INC-28 with the Registrar of Companies.

Share Transfer Breakdown

The acquired shares originated from two specific transferor companies that held stakes in Nath Bio-Genes:

Shareholding Structure

Following the acquisition, the promoter and promoter group shareholding structure of Nath Bio-Genes remains as follows:

Regulatory Compliance

Tapovan Paper has filed the necessary disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The company emphasized that this acquisition represents a transfer of shares among existing promoter group entities and does not result in any change to the aggregate shareholding of the promoter and promoter group of Nath Bio-Genes.

The target company, Nath Bio-Genes (India) Limited, maintains its equity share capital of ₹19.00 crores, divided into 1,90,04,000 equity shares of ₹10.00 each. The company's shares are listed on both BSE Limited and the National Stock Exchange of India Limited.

Corporate Structure Impact

The amalgamation scheme has resulted in the consolidation of multiple entities under Tapovan Paper and Board Mills Limited. The actual transfer of the Nath Bio-Genes shares will be effected in due course, as indicated in the regulatory filing dated January 13, 2026. This corporate restructuring appears to be part of a broader organizational consolidation within the promoter group structure.